
| 1y | 3y | 5y | 10y | |
|---|---|---|---|---|
| Total Return (%) | 7.12 | 14.57 | 14.98 | 10.35 |
| Benchmark (%) | 7.58 | 15.51 | 13.66 | 9.96 |
| Morningstar Category Avg. (%) | 6.09 | 15.19 | 14.48 | 9.73 |
| Morningstar Ranking | 143/406 | 197/378 | 131/355 | 87/285 |
| Morningstar Quartile | 2 | 3 | 2 | 2 |
| Lipper Category Avg. (%) | 5.97 | 14.99 | 12.89 | 9.80 |
| Lipper Ranking | 36/151 | 67/144 | 54/136 | 26/106 |
| Lipper Quartile | 1 | 2 | 2 | 1 |
| YTD | 1m | 3m | 1y | 3y | 5y | 10y | |
|---|---|---|---|---|---|---|---|
| Total Return (%) | 10.47 | 0.85 | 5.49 | 7.12 | 50.41 | 100.96 | 167.68 |
| Benchmark (%) | 9.50 | 1.27 | 6.18 | 7.58 | 54.13 | 89.73 | 158.48 |
| Morningstar Category Avg. (%) | 7.87 | 0.24 | 5.68 | 6.09 | 52.83 | 96.66 | 153.03 |
| Lipper Category Avg. (%) | 6.89 | 0.46 | 4.88 | 5.97 | 52.30 | 84.05 | 156.38 |
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Total Return (%) | 6.59 | 25.81 | -4.52 | 12.00 | 8.88 |
| Benchmark (%) | 4.96 | 28.34 | -12.03 | 12.71 | 13.07 |
| Morningstar Category Avg. (%) | 2.63 | 29.32 | -8.02 | 13.94 | 11.43 |
Performance is shown after deduction of ongoing charges. Any entry and exit charges are excluded from the calculation.
This information must be preceded or accompanied by a current prospectus. For standardized performance, please see the Performance section above.
| Gross Expense Ratio | 1.44% |
| Net Expense Ratio | 1.25% |
Net Expense Ratio excluding Investment Related Expenses is 1.24%
| Name | Weight (%) |
|---|---|
| FIRST CITIZENS BANCSHARES INC (DELAWARE) | 2.87 |
| SS&C TECHNOLOGIES HOLDINGS INC | 2.66 |
| CARDINAL HEALTH INC | 2.49 |
| WESTERN DIGITAL CORPORATION | 2.11 |
| BECTON DICKINSON AND COMPANY | 2.07 |
| Name | Weight (%) |
|---|---|
| CVS HEALTH CORP | 2.06 |
| WESCO INTERNATIONAL INC | 2.00 |
| FIDELITY NATIONAL INFORMATION SERVICES INC | 1.97 |
| MAXIMUS INC | 1.87 |
| SPDR S&P BIOTECH ETF | 1.86 |
| Name | Market Value | Weight (%) | Shares |
|---|
This fund does not seek to follow a sustainable, impact or ESG investment strategy. For more information regarding the fund's investment strategy, please see the fund's prospectus or, as applicable, shareholder report.